AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23648640
Drug: Disulfiram (0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disulfiram (0, 250, 375, or 500 mg/d)
Trial: 16492207
Drug: Pioglitazone (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (initial dose 15 mg/day, increased to 30 mg/day)
Trial: 16492207
Drug: Voglibose (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voglibose (initial dose 0.6 mg/day, increased to 0.9 mg/day)
Trial: 15611421
Drug: Traditional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional therapy group
Trial: 9294378
Drug: Medication alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication alone for 14 months
Trial: 9294378
Drug: Psychosocial treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychosocial treatment alone for 14 months
Trial: 9294378
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of medication and psychosocial treatment for 14 months
Trial: 8403175
Drug: Regularly dosed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regularly dosed oral morphine (20 mg every four hours)
Trial: 8403175
Drug: Oral placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral placebo (equivalent dose every four hours)
Trial: 31472099
Drug: Emollient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emollient treatment
Trial: 27716604
Drug: Cilostazol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilostazol (100 mg, oral, twice a day for 4 weeks)
Trial: 27716604
Drug: Placebo (matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matching placebo, oral, twice a day for 4 weeks)
Trial: 22555328
Drug: Cefaclor, 50
RxNorm normalized name: Cefaclor, 500 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor, 50 mg/kg/day, administered twice daily for five days
Trial: 22555328
Drug: Amoxicillin/clavulanate, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate, 40 mg/kg/day administered twice daily for 10 days
Trial: 12378667
Drug: Rocuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.1 mg kg‐1
Trial: 12378667
Drug: Rocuronium 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.15 mg kg‐1
Trial: 12378667
Drug: Rocuronium 0.22
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.22 mg kg‐1
Trial: 12378667
Drug: Rocuronium 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.3 mg kg‐1
Trial: 12378667
Drug: Rocuronium 0.29
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.29 mg kg‐1 (ED95)
Trial: 10529324
Drug: Streptokinase therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase therapy with r-hirudin or heparin
Trial: 2270358
Drug: Dichloroacetate (DCA)
RxNorm normalized name: dichloroacetate
DrugBank: Sodium dichloroacetate (DB16929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dichloroacetate (DCA) 50 mg.kg‐1.h‐1
Trial: 531232
Drug: Tolfenamic acid
RxNorm normalized name: Tolfenamic acid
DrugBank: Tolfenamic acid (DB09216)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolfenamic acid (200 mg x 3)
Trial: 531232
Drug: Indomethacin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (25 mg x 3)
Trial: 531232
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (0.5 g x 3)
Trial: 24052453
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment in specialty outpatient addiction treatment program
Trial: 22703421
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol 400 μg
Trial: 22703421
Drug: Intramuscular oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular oxytocin 10 iu
Trial: 19224679
Drug: ACTS infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACTS infusion intervention
Trial: 17805075
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (30 microg of ethinyl estradiol and 0.3 mg of norgestrel) for 2 years
Trial: 15356032
Drug: Essential amino
RxNorm normalized name: Essential amino acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential amino acids and carbohydrates supplementation (16.5 g essential amino acids and 30 g carbohydrates at 1100, 1600, and 2100 h)
Trial: 12174005
Drug: Ivermectin 200
RxNorm normalized name: ivermectin 200 ug / praziquantel 1.5 mg ORAL PASTE [Equimax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin 200 micro g/kg orally
Trial: 10442367
Drug: Paclitaxel (175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (175 mg/m2 IV infusion on day 1) and UFT (300-600 mg/day orally) plus oral calcium folinate (90 mg/day in three divided doses for 14 days)
Trial: 10442367
Drug: UFT (300-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT (300-600 mg/day orally) plus oral calcium folinate (90 mg/day in three divided doses for 14 days)
Trial: 10442367
Drug: Paclitaxel (175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (175 mg/m2 IV infusion on day 1)
Trial: 10442367
Drug: UFT (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT (600 mg/day orally)
Trial: 7822661
Drug: Budesonide doses
RxNorm normalized name: budesonide Metered Dose Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide doses
Trial: 708024
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 200 mg doxycycline (or 4 mg/kg in patients less than 15 years old)
Trial: 708024
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of doxycycline, 500 mg over 4 days (or 10 mg/kg in patients less than 15 years old)
Trial: 708024
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 200 mg doxycycline (or 4 mg/kg in children)
Trial: 28052471
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health education computer game
Trial: 23416718
Drug: Remifentanil (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil (2 ng.ml‐1 target)
Trial: 23416718
Drug: Sufentanil (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil (0.2 ng.ml‐1 target)
Trial: 16923247
Drug: Allopurinol (an
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (an inhibitor of xanthine oxidase)
Trial: 15606222
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone 1g and intravenous azithromycin 500 mg daily
Trial: 15606222
Drug: Intravenous levofloxacin
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous levofloxacin 500 mg daily
Trial: 14752875
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy intervention (five sessions of physical therapy and an individualized home exercise program)
Trial: 6786730
Drug: Protective environment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protective environment with prophylactic oral nonabsorbable antibiotics
Trial: 30886898
Drug: Budesonide combined
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide combined with noninvasive mechanical ventilation (10 days treatment)
Trial: 28146658
Drug: Bicalutamide (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicalutamide (150 mg daily for 24 months)
Trial: 25957224
Drug: Clopidogrel-aspirin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel-aspirin therapy (loading dose of 300 mg of clopidogrel on day 1, followed by 75 mg of clopidogrel per day for 90 days, plus 75 mg of aspirin per day for the first 21 days)
Trial: 25957224
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (75 mg/d for 90 days)
Trial: 17251510
Drug: Probiotic cheese
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic cheese (50 g daily)
Trial: 17251510
Drug: Control cheese
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control cheese (50 g daily)
Trial: 15823764
Drug: Oxycodone 5
RxNorm normalized name: oxycodone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone 5 mg/ibuprofen 400 mg
Trial: 11525072
Drug: Physical exercise
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical exercise program for eight months, with an intensity of 60% to 80% of heart rate reserve, consisting of three weekly sessions of 60 minutes each.
Trial: 22634964
Drug: Acute bicarbonate
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute bicarbonate (0.3 g/kg BM)
Trial: 22634964
Drug: Chronic bicarbonate
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic bicarbonate (0.5 g/kg BM daily for 3 days)
Trial: 1410168
Drug: Nasal nicotine
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal nicotine spray (2 mg nicotine base, mean 27.8 micrograms/kg)
Trial: 1410168
Drug: Nasal nicotine
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal nicotine spray
Trial: 1410168
Drug: Nasal nicotine
RxNorm normalized name: nicotine Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal nicotine spray (ad libitum use)
Trial: 31305874
Drug: Nabiximols (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabiximols (up to 32 sprays daily, containing 86.4 mg tetrahydrocannabinol and 80 mg cannabidiol)
Trial: 28899206
Drug: Augmented acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmented acupuncture (LI4, LIV3, EX-HN3, GV20, LU7, KID6, including intradermal needles for sustained treatment)
Trial: 27418034
Drug: Fortified cereal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified cereal (50 g) with 150 ml semi-skimmed milk, consumed daily for 12 weeks
Trial: 27418034
Drug: Unfortified cereal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfortified cereal (50 g) with 150 ml semi-skimmed milk, consumed daily for 12 weeks
Trial: 27418034
Drug: Fortified cereal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fortified cereal (50 g) with 150 ml semi-skimmed milk
Trial: 22699751
Drug: Lutein (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein (10 mg daily for up to 3 months)
Trial: 22699751
Drug: Zeaxanthin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zeaxanthin (10 mg daily for up to 3 months)
Trial: 2145718
Drug: Subunit plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subunit plasma vaccine against hepatitis B, administered in three injections.
Trial: 28584075
Drug: Sensor augmented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensor augmented pump (SAP) therapy
Trial: 9666940
Drug: 0.025 mg/day
RxNorm normalized name: estradiol 0.025 MG/Day Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025 mg/day transdermal 17 beta‐estradiol
Trial: 9666940
Drug: 0.05 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 mg/day transdermal 17 beta‐estradiol
Trial: 9666940
Drug: 0.1 mg/day
RxNorm normalized name: Lyllana 0.1 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/day transdermal 17 beta‐estradiol
Trial: 7867109
Drug: meperidine 50
RxNorm normalized name: meperidine 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meperidine 50 mg with diazepam approximately 90 micrograms.kg‐1 (Group D)
Trial: 628532
Drug: Insulin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (20 units NPH and 10 units regular) and diabetic diet
Trial: 628532
Drug: Neither diet
RxNorm normalized name: 2,2',3,3',4,4',5,5',6-nonachlorodiphenyl either
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neither diet nor insulin
Trial: 23126214
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg diclofenac p.o. one hour prior to surgery
Trial: 18593060
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (4g)
Trial: 10795554
Drug: iopromid (low‐osmolar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iopromid (low‐osmolar non‐ionic contrast agent)
Trial: 8667132
Drug: Etodolac (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etodolac (300 mg capsules, 2 taken 30 minutes prior to surgery, redosed prn)
Trial: 8667132
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of acetaminophen with hydrocodone (not premedicated, prn regimen)
Trial: 1653901
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of morphine intraarticularly and saline intravenously (Group 1)
Trial: 1653901
Drug: Saline intraarticularly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline intraarticularly and 1 mg of morphine intravenously (Group 2)
Trial: 1653901
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg of morphine intraarticularly and saline intravenously (Group 3)
Trial: 1653901
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of morphine and 0.1 mg of naloxone intraarticularly and saline intravenously (Group 4)
Trial: 6687805
Drug: Spinal anaesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anaesthesia with amethocaine 12‐14 mg plus morphine 1 mg (group II)
Trial: 6687805
Drug: Spinal anaesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anaesthesia with amethocaine 12‐14 mg (group I)
Trial: 30400726
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of pantoprazole
Trial: 30400726
Drug: Intermittent dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent dosing with pantoprazole
Trial: 26905932
Drug: Task-sharing counselling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Task-sharing counselling intervention for maternal depression (details on dosage and duration not available)
Trial: 22546716
Drug: Incorporating 60
RxNorm normalized name: Liposome-incorporated DTP-GDP
DrugBank: Liposomal N-acetylglucosminyl-N-acetylmuramly-L-Ala-D-isoGln-L-Ala-gylceroldipalmitoyl (DB17316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incorporating 60 g/day whole grains into the diet for 16 weeks
Trial: 22546716
Drug: Incorporating 60
RxNorm normalized name: Liposome-incorporated DTP-GDP
DrugBank: Liposomal N-acetylglucosminyl-N-acetylmuramly-L-Ala-D-isoGln-L-Ala-gylceroldipalmitoyl (DB17316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incorporating 60 g/day whole grains into the diet for 8 weeks, doubling to 120 g/day for the following 8 weeks
Trial: 20193253
Drug: Aminophylline delivered
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline delivered via remote controlled capsule to the small bowel
Trial: 20193253
Drug: Aminophylline delivered
RxNorm normalized name: Aminophylline
DrugBank: Aminophylline (DB01223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline delivered via remote controlled capsule to the ascending colon
Trial: 18577477
Drug: Urso treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urso treatment
Trial: 18577477
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no urso treatment)
Trial: 6122100
Drug: GL enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GL enzyme (hyaluronidase preparation)
Trial: 12375683
Drug: nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nifedipine 10 mg orally every 4 h
Trial: 9928780
Drug: Sufentanil 5
RxNorm normalized name: SUFentanil 50 MCG in 1 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 5 mg
Trial: 31145173
Drug: Intravenous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propofol 1 to 2 mg/kg pretreatment to deepen anesthesia to BIS<40
Trial: 31145173
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group - intravenous saline pretreatment before PCTG puncture and anesthesia targeted to BIS 40 to 60
Trial: 31145173
Drug: Study group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Study group - intravenous propofol 1 to 2 mg/kg pretreatment
Trial: 30286558
Drug: α-Lipoic Acid
RxNorm normalized name: α-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-Lipoic Acid (ALA) 900 mg daily for 10 days
Trial: 24352340
Drug: udenafil 100
RxNorm normalized name: udenafil
DrugBank: Udenafil (DB06267)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: udenafil 100 mg/day
Trial: 20029053
Drug: Video self-modeling
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Video self-modeling (VSM) following speech restructuring treatment
Trial: 16280763
Drug: Bicalutamide 150
RxNorm normalized name: bicalutamide 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicalutamide 150 mg + Tamoxifen 10 mg
Trial: 16280763
Drug: Bicalutamide 150
RxNorm normalized name: bicalutamide 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicalutamide 150 mg + Radiotherapy (RT)
Trial: 12442242
Drug: Comparison treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison treatment (papain or vinegar)
Trial: 12442242
Drug: Hot-water immersion
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hot-water immersion vs Comparison treatment
Trial: 10624639
Drug: Fentanyl 100
RxNorm normalized name: FENTANYL 100MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 100 micrograms loading dose and 70 micrograms.h‐1 continuous infusion
Trial: 10624639
Drug: Fentanyl 200
RxNorm normalized name: fentaNYL 200 mcg buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 200 micrograms loading dose and 150 micrograms.h‐1 continuous infusion
Trial: 1974686
Drug: formoterol (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: formoterol (12 micrograms inhalation b.i.d.)
Trial: 1974686
Drug: salbutamol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: salbutamol (200 micrograms inhalation q.i.d.)
Trial: 7426230
Drug: Hyperbaric solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric solution (10 mg amethocaine)
Trial: 7426230
Drug: Hyperbaric solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric solution (15 mg amethocaine)
Trial: 7426230
Drug: Isobaric solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isobaric solution (10 mg amethocaine)
Trial: 7426230
Drug: Isobaric solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isobaric solution (15 mg amethocaine)
Trial: 7426230
Drug: Hypobaric solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypobaric solution (10 mg amethocaine)
Trial: 7426230
Drug: Hypobaric solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypobaric solution (15 mg amethocaine)
Trial: 7426230
Drug: Amethocaine 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amethocaine 15 mg
Trial: 7426230
Drug: Amethocaine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amethocaine 10 mg
Trial: 24678066
Drug: Muscle patch
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muscle patch
Trial: 18502162
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human arylsulfatase B (rhASB) at 1 mg/kg weekly infusions
Trial: 15895275
Drug: Subcutaneous IFNbeta‐1b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous IFNbeta‐1b (Betaferon) treatment
Trial: 12233808
Drug: Ginger syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger syrup (1 tablespoon in 4 to 8 ounces of hot or cold water, 4 times daily)
Trial: 12233808
Drug: Placebo syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo syrup (1 tablespoon in 4 to 8 ounces of hot or cold water, 4 times daily)
Trial: 12233808
Drug: Ginger syrup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger syrup
Trial: 7778813
Drug: Cephalosporine 1
RxNorm normalized name: Cephalosporium roseum
DrugBank: Cephalosporium roseum (DB10932)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalosporine 1 (5-day administration)